- 31/10/2008 - Appendix 4C - Quarterly Report 30 September 2008
- 13/10/2008 - Presentation to Annual General Meeting
- 13/10/2008 - Resolutions Passed at Annual General Meeting
- 15/09/2008 - Annual Report for year ended 30 June 2008 and Notice of Annual General Meeting
- 9/09/2008 - BIT225 Highly Synergistic with New Class of Anti-HCV Therapies
- 29/08/2008 - Year End Accounts and Preliminary Final Report for year ended 30 June 2008
- 14/08/2008 - Biotron Expands HCV Clinical Trial to a Second Site
- 8/08/2008 - Change of Address Details
- 7/08/2008 - Phase Ib/IIa HCV Clinical Trial Commenced
- 23/07/2008 - Appendix 4C - Quarterly Report 30 June 2008
- 22/05/2008 - Underwriting Agreement - New Issue Announcement
- 9/05/2008 - Shareholder Update - May edition of BITNews
- 22/04/2008 - Appendix 4C - Quarterly Report 31 March 2008
- 31/03/2008 - Underwriting Agreement - New Issue Announcement
- 11/03/2008 - Presentation of Biotron's HIV and HCV Programs at International Partnering Meeting
- 21/02/2008 - Appendix 4D - Half Year Report 31 December 2007
- 30/01/2008 - Appendix 4C - Quarterly Report 31 December 2007
